Strong industry performance, consistent earnings, and optimistic future growth are driving stock prices for Molina Healthcare (MOH), with numerous occasions of beating quarterly earnings and revenue estimates. Analysts affirm that the stock is outpacing its medical peers in the stock market. Highlights include Victory Capital Management selling off its substantial shareholding, and a neutral initiation of coverage by UBS. In recent news, MOH managed to secure a Medicaid deal from New Mexico HSD and posted impressive premium growth, leading to an upbeat outlook for 2023.
MOH is reported to be fundamentally undervalued, providing a potential opportunity for value investors. Directors and CFOs selling off significant shares, however, may impart mild skepticism among investors. Despite that, acquisition of Bright HealthCare's California Medicare business, clinching a Michigan Medicaid contract, and robust financial results signal strong position for MOH. There is praise for the company's cautious debt handling and increasing relative strength rating.
Molina Healthcare MOH News Analytics from Mon, 03 Jul 2023 07:00:00 GMT to Sun, 12 May 2024 12:09:34 GMT - Rating 6 - Innovation -2 - Information 6 - Rumor -2
